How Can Interleukin-1 Receptor Antagonist Modulate Distinct Cell Death Pathways?
Ontology highlight
ABSTRACT: Multiple mechanisms of cell death exist (apoptosis, necroptosis, pyroptosis) and the subtle balance of several distinct proteins and inhibitors tightly regulates the cell fate toward one or the other pathway. Here, by combining coimmunoprecipitation, enzyme assays, and molecular simulations, we ascribe a new role, within this entangled regulatory network, to the interleukin-1 receptor antagonist (IL-1Ra). Our study enlightens that IL-1Ra, which usually inhibits the inflammatory effects of IL-1α/β by binding to IL-1 receptor, under advanced pathological states prevents apoptosis and/or necroptosis by noncompetitively inhibiting the activity of caspase-8 and -9. Consensus docking, followed by cumulative 10 μs of molecular dynamics simulations unprecedentedly reveal that IL-1Ra binds both cas
SUBMITTER: Spinello A
PROVIDER: S-EPMC6545110 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA